New and Revised Draft Q&As on Biosimilar Development and the BPCI Act (Revision 4) Draft Guidance for Industry March 2026

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/new-and-revised-draft-qas-biosimilar-development-and-bpci-act-revision-4?utm_medium=email&utm_source=govdelivery